Interview of our President & CEO published in the magazine PharmaBoardroom

New article and interview of our President & CEO Eric Halioua for the 2020 edition of the Belgium Healthcare & Life Science Review of the magazine PharmaBoardroom. He introduces the Belgian immuno-onco biotech, our clinical-stage assets, the impact of the firm’s collaboration with Korean LG Chem, and future internationalisation strategies!

The Belgian Review will be published in US-headquartered reference publication Pharmaceutical Executive. Pharmaceutical Executive provides 'C'-level (Chairman, CEO, COO and CFO) executives and other strategic decision-makers with vital information regarding investment opportunities, pipeline reports, company rankings, mergers & acquisitions (M&A), regulation, and other topics. Pharmaceutical Executive is considered within the pharmaceutical and healthcare industry as the authoritative monthly resource for reaching and understanding strategic trends and markets. The publication Is circulated through subscription and reaches 110,000 executive readers throughout the Americas, Europe, and Asia.

Click on the link below to get access to the full article:

https://pharmaboardroom.com/interviews/eric-halioua-president-ceo-pdcline-pharma-belgium/